Form 4: Definitive Healthcare CEO Reports Routine Share Withholding
Insider Transaction Report
Definitive Healthcare Corp. CEO Kevin Coop reported a disposition of 37,593 Class A Common Stock shares for tax withholding purposes related to restricted stock unit vesting.
Summary
- Kevin Coop, Chief Executive Officer and Director of Definitive Healthcare Corp. (DH), reported a transaction involving Class A Common Stock.
- On October 1, 2025, Mr. Coop disposed of 37,593 shares of Class A Common Stock.
- This disposition was executed at a price of $3.56 per share.
- The transaction code 'F' indicates that these shares were withheld by the issuer to satisfy tax withholding obligations associated with the vesting and settlement of previously reported restricted stock units.
- Following this transaction, Mr. Coop beneficially owns 3,584,788 shares of Class A Common Stock directly.
- An exhibit to the filing includes a Power of Attorney, dated July 10, 2025, authorizing specific individuals to execute SEC Forms 3, 4, and 5 on behalf of Kevin Coop.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is a neutral event and does not indicate significant positive or negative sentiment regarding the company's performance or outlook.
Negatives
- The transaction represents a reduction in the CEO's direct beneficial ownership by 37,593 shares, although it is for tax withholding purposes rather than a discretionary sale.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This routine insider transaction filing does not provide specific information that directly relates to broader industry trends or competitive landscape analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization | Kevin Coop granted a Power of Attorney to Jonathan Paris, Maria Borda, Casey Heller, and Christina Kelleher to prepare, execute, and submit SEC Forms 3, 4, and 5 on his behalf. | 07/10/2025 | This streamlines the process for insider reporting compliance, ensuring timely and accurate filings with the SEC. |
Stakeholder Impact
- Shareholders: The transaction is a routine compliance event and is unlikely to have a material impact on shareholder value or perception.
- Management: The CEO's beneficial ownership is slightly reduced due to tax obligations, a standard practice for equity compensation.
Key Dates
| Date | Description |
|---|---|
| 07/10/2025 | Date of Power of Attorney granted by Kevin Coop. |
| 10/01/2025 | Transaction date for the disposition of Class A Common Stock. |
| 10/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe filing details a routine tax withholding transaction by the CEO, which does not reflect a discretionary sale or provide new information impacting the company's fundamentals or future prospects. Therefore, it does not warrant a change in investment recommendation.
Keywords
Definitive Healthcare, DH, Kevin Coop, Form 4, Insider Transaction, Share Withholding, Restricted Stock Units, CEO, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.